These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39028033)

  • 1. Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases.
    Arenhoevel J; Kuppe A; Addante A; Wei LF; Boback N; Butnarasu C; Zhong Y; Wong C; Graeber SY; Duerr J; Gradzielski M; Lauster D; Mall MA; Haag R
    Biomater Sci; 2024 Aug; 12(17):4376-4385. PubMed ID: 39028033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases.
    Addante A; Raymond W; Gitlin I; Charbit A; Orain X; Scheffler AW; Kuppe A; Duerr J; Daniltchenko M; Drescher M; Graeber SY; Healy AM; Oscarson S; Fahy JV; Mall MA
    Eur Respir J; 2023 May; 61(5):. PubMed ID: 37080569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases.
    Ehre C; Rushton ZL; Wang B; Hothem LN; Morrison CB; Fontana NC; Markovetz MR; Delion MF; Kato T; Villalon D; Thelin WR; Esther CR; Hill DB; Grubb BR; Livraghi-Butrico A; Donaldson SH; Boucher RC
    Am J Respir Crit Care Med; 2019 Jan; 199(2):171-180. PubMed ID: 30212240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
    Yuan S; Hollinger M; Lachowicz-Scroggins ME; Kerr SC; Dunican EM; Daniel BM; Ghosh S; Erzurum SC; Willard B; Hazen SL; Huang X; Carrington SD; Oscarson S; Fahy JV
    Sci Transl Med; 2015 Feb; 7(276):276ra27. PubMed ID: 25717100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.
    Horsley A; Rousseau K; Ridley C; Flight W; Jones A; Waigh TA; Thornton DJ
    J Cyst Fibros; 2014 May; 13(3):260-6. PubMed ID: 24332705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.
    Livraghi-Butrico A; Grubb BR; Wilkinson KJ; Volmer AS; Burns KA; Evans CM; O'Neal WK; Boucher RC
    Mucosal Immunol; 2017 May; 10(3):829. PubMed ID: 28435155
    [No Abstract]   [Full Text] [Related]  

  • 7. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
    Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
    Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
    Henke MO; John G; Germann M; Lindemann H; Rubin BK
    Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucins: the frontline defence of the lung.
    Ridley C; Thornton DJ
    Biochem Soc Trans; 2018 Oct; 46(5):1099-1106. PubMed ID: 30154090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma.
    Welsh KG; Rousseau K; Fisher G; Bonser LR; Bradding P; Brightling CE; Thornton DJ; Gaillard EA
    Chest; 2017 Oct; 152(4):771-779. PubMed ID: 28716644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.
    Suk JS; Boylan NJ; Trehan K; Tang BC; Schneider CS; Lin JM; Boyle MP; Zeitlin PL; Lai SK; Cooper MJ; Hanes J
    Mol Ther; 2011 Nov; 19(11):1981-9. PubMed ID: 21829177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine.
    Suk JS; Lai SK; Boylan NJ; Dawson MR; Boyle MP; Hanes J
    Nanomedicine (Lond); 2011 Feb; 6(2):365-75. PubMed ID: 21385138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease.
    Pritchard MF; Powell LC; Menzies GE; Lewis PD; Hawkins K; Wright C; Doull I; Walsh TR; Onsøyen E; Dessen A; Myrvold R; Rye PD; Myrset AH; Stevens HN; Hodges LA; MacGregor G; Neilly JB; Hill KE; Thomas DW
    Mol Pharm; 2016 Mar; 13(3):863-72. PubMed ID: 26833139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
    Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
    Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of mucus concentration and secreted mucins Muc5ac and Muc5b to the pathogenesis of muco-obstructive lung disease.
    Livraghi-Butrico A; Grubb BR; Wilkinson KJ; Volmer AS; Burns KA; Evans CM; O'Neal WK; Boucher RC
    Mucosal Immunol; 2017 Mar; 10(2):395-407. PubMed ID: 27435107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucolytic activity of bacterial and human chitinases.
    Sanders NN; Eijsink VG; van den Pangaart PS; Joost van Neerven RJ; Simons PJ; De Smedt SC; Demeester J
    Biochim Biophys Acta; 2007 May; 1770(5):839-46. PubMed ID: 17321686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus.
    Fernandez-Petty CM; Hughes GW; Bowers HL; Watson JD; Rosen BH; Townsend SM; Santos C; Ridley CE; Chu KK; Birket SE; Li Y; Leung HM; Mazur M; Garcia BA; Evans TIA; Libby EF; Hathorne H; Hanes J; Tearney GJ; Clancy JP; Engelhardt JF; Swords WE; Thornton DJ; Wiesmann WP; Baker SM; Rowe SM
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gel-forming mucins form distinct morphologic structures in airways.
    Ostedgaard LS; Moninger TO; McMenimen JD; Sawin NM; Parker CP; Thornell IM; Powers LS; Gansemer ND; Bouzek DC; Cook DP; Meyerholz DK; Abou Alaiwa MH; Stoltz DA; Welsh MJ
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):6842-6847. PubMed ID: 28607090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung.
    Groneberg DA; Eynott PR; Oates T; Lim S; Wu R; Carlstedt I; Nicholson AG; Chung KF
    Respir Med; 2002 Feb; 96(2):81-6. PubMed ID: 11860173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.